Synthesis and antimicrobial activity of 5-hydroxymethyl- 8-methyl-2-(N-arylimino)-pyrano[2,3-c]pyridine-3-(N-aryl)-carboxamides

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 24, 2005, Pages 5483-5487

  Zhuravel, Irina O ^a   Kovalenko, Sergiy M ^b   Ivachtchenko, Alexandre V ^c   Balakin, Konstantin V ^c   Kazmirchuk, Victor V ^d  

^a NATIONAL UNIVERSITY OF PHARMACY   (Ukraine)

^b Institute of Combinatorial Organic Chemistry   (Ukraine)

^c CHEMDIV INC   (United States)

^d The National Academy of Medical Sciences of Ukraine   (Ukraine)

Author keywords

Compound library; Pyrano 2,3 c pyridine

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AROMATIC AMINE; CIPROFLOXACIN; FLUCONAZOLE; PYRIDINE DERIVATIVE; PYRIDOXAL;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS; BACILLUS ANTHRACOIDES; BACTERIAL STRAIN; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SYNTHESIS; ESCHERICHIA COLI; FUNGAL STRAIN; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; CANDIDA ALBICANS; CIPROFLOXACIN; FLUCONAZOLE; MICROBIAL SENSITIVITY TESTS; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

BACILLUS (BACTERIUM); BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 27644484537     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.08.081     Document Type: Article

References (16)

1. Huang, C.-K.; US Patent 5648378, 1997; Chem. Abstr. 1997, 126, 131382U.
2. I.E. Bylov, M.V. Vasylyev, and Y.V. Bilokin Eur. J. Med. Chem. 34 1999 997
3. J.A. Hadfield, V.H. Pavlidis, P.J. Perry, and A.T. McGown Anti-Cancer Drugs 10 1999 591
4. S.Y. Cho, S.Y. Kang, S.S. Kim, H.G. Cheon, J.-K. Choi, and E.K. Yum Bull. Korean. Chem. Soc. 22 2001 1217
5. R.A. Mekheimer, N.H. Mohamed, and K.U. Sadek Bull. Chem. Soc. Jpn. 70 1997 1625
6. E.V. Stoyanov, I.C. Ivanov, and D. Heber Molecules 5 2000 19
7. I.O. Zhuravel', S.M. Kovalenko, A.V. Ivachtchenko, V.P. Chernykh, and P.E. Shinkarenko J. Heterocycl. Chem. 41 2004 517
8. Y.V. Bilokin, S.N. Kovalenko, I.E. Bylov, V.P. Chernykh, O.V. Branytska, and S.M. Kovalenko Heterocycl. Commun. 4 1998 257
9. S.N. Kovalenko, I.E. Bylov, Ya.V Belokon, and V.P. Chernykh Chem. Heterocycl. Comp. (New York) (Khim. Geterotsikl. Soed) 36 2000 1026
10. S.N. Kovalenko, I.E. Bylov, Belokon, K.M. Sytnik, V.P. Chernykh, and Y.V. Bilokin Molecules 5 2000 1146
11. 3: C, 66.86; H, 5.30; N, 13.00. Found: C, 66.87; H, 5.29; N, 13.00.
12. Y.V. Bilokin, M.V. Vasylyev, O.V. Branytska, S.M. Kovalenko, and V.P. Chernykh Tetrahedron 55 1999 13757
13. 4: C, 59.52; H, 3.95; N, 8.68. Found: C, 59.50; H, 3.96; N, 8.68.
14. M.L. Dhar, M.M. Dhar, B.N. Dhawan, B.N. Mehrotra, and C. Ray Indian J. Exp. Biol. 6 1968 232
15. 5 cfu/mL). The tubes were incubated at 37°C for bacteria (for 18-24 h) and 30°C for fungi (for 48 h). The MICs (in μg/mL) were recorded by visual observation.
16. R. Davis, A. Markham, and J.A. Balfour Drugs 51 1996 1019